SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-24-060119
Filing Date
2024-07-09
Accepted
2024-07-09 16:02:40
Documents
1
Period of Report
2024-07-05

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3896
  Complete submission text file 0001213900-24-060119.txt   5411
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-4597
Virpax Pharmaceuticals, Inc. (Issuer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 6800 INDIAN CREEK DR. SUITE 1E MIAMI BEACH FL 33141
Business Address
Dhaliwal Jatinder (Reporting) CIK: 0002018476 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40064 | Film No.: 241107486